September 12, 2024

New Molecular Engineering Technique Allows for Complex Organoids

New Molecular Engineering Technique Allows for Complex Organoids

Interdisciplinary research team uses DNA microbeads to control the development of cultivated tissue

A new molecular engineering technique can precisely influence the development of organoids. Microbeads made of specifically folded DNA are used to release growth factors or other signal molecules inside the tissue structures. This gives rise to considerably more complex organoids that imitate the respective tissues much better and have a more realistic cell mix than before. An interdisciplinary research team from the Cluster of Excellence “3D Matter Made to Order” with researchers based at the Centre for Organismal Studies and the Center for Molecular Biology of Heidelberg University, the university’s BioQuant Center as well as the Max Planck Institute for Medical Research in Heidelberg developed the technique.

Organoids are miniature, organ-like tissue structures derived from stem cells. They are used in basic research to gain new insights into human development or to study the development of diseases. “Until now it wasn’t possible to control the growth of such tissue structures from their interior,” states Dr Cassian Afting, a Physician Scientist at the Centre for Organismal Studies (COS). “Using the novel technique, we can now determine precisely when and where in the growing tissue key developmental signals are released,” emphasizes Tobias Walther, a biotechnologist and doctoral candidate at the Center for Molecular Biology of Heidelberg University (ZMBH) and the Max Planck Institute for Medical Research in Heidelberg.

The interdisciplinary research team of biologists, physicians, physicists, and materials scientists constructed microscopically small beads of DNA that can be “loaded” with proteins or other molecules. These microbeads are injected into the organoids and release their cargo when exposed to UV light. This allows the release of growth factors or other signal molecules at any given time and location within the developing tissue.

The researchers tested the process on retinal organoids of the Japanese rice fish medaka by precisely inserting microbeads loaded with a Wnt signal molecule into the tissue. For the first time, they were able to induce retinal pigment epithelial cells – the outer layer of the retina – to form adjacent to neural retinal tissue. Previously, adding Wnt to the culture media would induce pigment cells but suppress neural retina development. “Thanks to the localized release of signaling molecules, we were able to achieve a more realistic mix of cell types, thereby more closely mimicking the natural cell composition of the fish eye than with conventional cell cultures,” explains Prof. Dr Kerstin Göpfrich, a researcher in the field of synthetic biology at the ZMBH and the Max Planck Institute for Medical Research.

According to the scientists, the DNA microbeads can be flexibly adapted to transport many different signal molecules in various types of cultivated tissue. “This opens up new possibilities for engineering organoids with improved cellular complexity and organization,” states Prof. Dr Joachim Wittbrodt, who directed the research work together with Prof. Göpfrich. “More sophisticated organoid models could accelerate research on human development and disease and potentially lead to better organoid-based drug research,” states the Heidelberg developmental biologist, whose research group is located at the COS.

The new technique for creating more complex organoids was developed in the Cluster of Excellence “3D Matter Made to Order”, which is operated jointly by Heidelberg University and the Karlsruhe Institute of Technology. The research work was funded by the European Research Council (ERC) within the framework of an ERC Starting Grant for Kerstin Göpfrich, and the German Research Foundation. A paper with the research results was published in the journal “Nature Nanotechnology”.

Retinal organoid with a microscopically small bead of DNA (yellow) and various retinal cell types (green, cyan, magenta). | © Cassian Afting, AG Wittbrodt

Original publication
C. Afting, T. Walther, O. M. Drozdowski, C. Schlagheck, U. S. Schwarz, J. Wittbrodt, K. Göpfrich: DNA microbeads for spatio-temporally controlled morphogen release within organoids. Nature Nanotechnology (9 September 2024).

Original News

Our latest News

discover more
TSG Hoffenheim and Heidelberg University Hospital cooperate

TSG Hoffenheim and Heidelberg University Hospital cooperate

TSG Hoffenheim and Heidelberg University Hospital (UKHD) are entering into a partnership to focus more on the topic of mental health. The aim of the cooperation is to bring the Clinic for Child and Adolescent Psychiatry, the Clinic for General Psychiatry and the Sports Psychology Department of TSG closer together. More Information in German below. […]

Award-winning research in emergency medicine in Heidelberg

Award-winning research in emergency medicine in Heidelberg

Research is constantly being conducted at Heidelberg University Hospital to continuously improve patient care and patient safety. The emergency medicine department has already received several awards for its innovations and improvements. The Emergency Medicine Section of the Department of Anesthesiology at Heidelberg University Hospital (UKHD) recently received the Rudolf Frey Prize 2024 from the German […]

Psychotherapy via video in the GP practice helps with depression and anxiety

Psychotherapy via video in the GP practice helps with depression and anxiety

A new digital therapy concept provides people suffering from mental disorders with low-threshold and effective access to specialized psychosocial care. This can usefully complement existing services – as demonstrated by the PROVIDE-C study conducted by the Medical Faculty of Heidelberg University. The study was funded by the Federal Ministry of Education and Research (BMBF). Its […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp